xCELLigence-based Cardiotoxicity Study Voted Paper of the Year

AstraZeneca’s in vitro analysis of kinase inhibitor-induced cardiotoxicity receives Drug Discovery Toxicology Paper of the Year Award(PRWeb March 30, 2018)Read the full story at http://www.prweb.com/releases/2018/03/prweb15375693.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news